Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pramlintide fda approval date?How long have hydroxyzine pamoate been on the market?How does renal function impact tigecycline's liver safety?Atorvastatin side effects heart palpitations?Can grapefruit consumption affect lipitor's efficacy?
See the DrugPatentWatch profile for Saphnelo
Saphnelo (anifrolumab) is given as an intravenous (IV) infusion. Standard dosing is 300 mg once every 4 weeks (every month). [1]
Dosing is every 4 weeks. Each infusion is part of a recurring maintenance schedule rather than a short, limited course. [1]
The provided information only specifies the standard adult dosing schedule (300 mg IV every 4 weeks) and does not describe dose adjustments for age, body weight, or organ impairment. [1]
The provided information does not include missed-dose instructions. For personal guidance, dosing timing should be confirmed with the prescribing clinician or infusion team. [1]
The dosing details are listed in the drug’s prescribing information. [1] Sources: [1] https://www.saphnelo.com/dosing.html
Other Questions About Saphnelo :